Corporate medicine is hijacking feminist narratives around empowerment and women’s rights to market technologies, tests and treatments that aren’t backed by evidence.
People with low-risk prostate cancer are more likely to die from something else. Overdiagnosis and overtreatment can lead to life-changing complications.
Direct-to-consumer tests are products marketed to any consumer who is willing to pay, without going through their GP. But some could do more harm than good.
About one in six pregnant women in Australia are now diagnosed with gestational diabetes. Rates have more than doubled since the thresholds for diagnosis were changed.
Prostate cancer is one of the most common cancers in men. Although watchful waiting is appropriate for low-risk cases, many are diagnosed at an advanced stage because of racial health disparities.
Just having hyperactive, impulsive, and inattentive symptoms is not sufficient to qualify for a diagnosis of ADHD. Symptoms need to have a negative effect.
How do you know if your child’s behaviour is normal or a sign of ADHD? The answer is not so clear cut. And now we have the evidence to show the consequences.
In our new study, we’ve found the majority of news stories are failing to cover potential downsides of early detection tests. This could be perpetuating the problem of overdiagnosis.
New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne